Vasopeptidase inhibition and angio-oedema

Lancet. 2000 Aug 19;356(9230):608-9. doi: 10.1016/S0140-6736(00)02596-4.
No abstract available

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angioedema / chemically induced*
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Heart Failure / complications
  • Heart Failure / drug therapy*
  • Humans
  • Lisinopril / adverse effects*
  • Lisinopril / therapeutic use
  • Neprilysin / antagonists & inhibitors*
  • Odds Ratio
  • Prognosis
  • Pyridines / adverse effects*
  • Pyridines / therapeutic use
  • Risk Assessment
  • Thiazepines / adverse effects*
  • Thiazepines / therapeutic use

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Pyridines
  • Thiazepines
  • omapatrilat
  • Lisinopril
  • Neprilysin